Batth IS - Search Results

1

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights.

Li H, Batth IS, Qu X, Xu L, Song N, Wang R, Liu Y. Li H, et al. Among authors: batth is. Mol Cancer. 2017 Jan 30;16(1):6. doi: 10.1186/s12943-016-0576-5. Mol Cancer. 2017. PMID: 28137302 Free PMC article. Review.

2

EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression.

Satelli A, Batth I, Brownlee Z, Mitra A, Zhou S, Noh H, Rojas CR, Li H, Meng QH, Li S. Satelli A, et al. Oncotarget. 2017 Jul 25;8(30):49329-49337. doi: 10.18632/oncotarget.17632. Oncotarget. 2017. PMID: 28521303 Free PMC article.

3

Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells.

Li H, Meng QH, Noh H, Batth IS, Somaiah N, Torres KE, Xia X, Wang R, Li S. Li H, et al. Among authors: batth is. Cancer Lett. 2017 Sep 10;403:216-223. doi: 10.1016/j.canlet.2017.05.032. Epub 2017 Jun 23. Cancer Lett. 2017. PMID: 28652021 Free PMC article.

4

Cell-surface vimentin-positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumors.

Li H, Meng QH, Noh H, Somaiah N, Torres KE, Xia X, Batth IS, Joseph CP, Liu M, Wang R, Li S. Li H, et al. Among authors: batth is. Oncoimmunology. 2018 Jan 8;7(5):e1420450. doi: 10.1080/2162402X.2017.1420450. eCollection 2018. Oncoimmunology. 2018. PMID: 29721368 Free PMC article.

5

Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patients.

Batth IS, Dao L, Satelli A, Mitra A, Yi S, Noh H, Li H, Brownlee Z, Zhou S, Bond J, Wang J, Gill J, Sholler GS, Li S. Batth IS, et al. Int J Cancer. 2020 Dec 15;147(12):3550-3559. doi: 10.1002/ijc.33140. Epub 2020 Jun 23. Int J Cancer. 2020. PMID: 32506485 Free PMC article.

6

Palmatine inhibits growth and invasion in prostate cancer cell: Potential role for rpS6/NFκB/FLIP.

Hambright HG, Batth IS, Xie J, Ghosh R, Kumar AP. Hambright HG, et al. Among authors: batth is. Mol Carcinog. 2015 Oct;54(10):1227-34. doi: 10.1002/mc.22192. Epub 2014 Jul 7. Mol Carcinog. 2015. PMID: 25043857 Free PMC article.

7

Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.

Batth IS, Yun H, Kumar AP. Batth IS, et al. Mol Carcinog. 2015 Oct;54(10):937-46. doi: 10.1002/mc.22354. Epub 2015 Jul 8. Mol Carcinog. 2015. PMID: 26152593 Review.

8

Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer.

Batth I, Yun H, Hussain S, Meng P, Osmulski P, Huang TH, Bedolla R, Profit A, Reddick R, Kumar A. Batth I, et al. Oncotarget. 2016 Mar 22;7(12):14048-63. doi: 10.18632/oncotarget.7287. Oncotarget. 2016. PMID: 26872377 Free PMC article.

9

Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients.

Satelli A, Batth IS, Brownlee Z, Rojas C, Meng QH, Kopetz S, Li S. Satelli A, et al. Among authors: batth is. Sci Rep. 2016 Jul 1;6:28910. doi: 10.1038/srep28910. Sci Rep. 2016. PMID: 27363678 Free PMC article.

10

Discovery of Cell-Surface Vimentin (CSV) as a Sarcoma Target and Development of CSV-Targeted IL12 Immune Therapy.

Batth IS, Li S. Batth IS, et al. Adv Exp Med Biol. 2020;1257:169-178. doi: 10.1007/978-3-030-43032-0_14. Adv Exp Med Biol. 2020. PMID: 32483739 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters